Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos

Detalhes bibliográficos
Ano de defesa: 2008
Autor(a) principal: Medeiros, Alessandra Azevedo Nascimento de
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal da Paraí­ba
BR
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://repositorio.ufpb.br/jspui/handle/tede/6861
Resumo: The pharmacological effects of Pradosia huberi (EHP) and Attalea excelsa (EAE) ethanolics extracts on the cardiovascular system were studied in rats using a combined in vivo and in vitro approach. In non-anaesthetized rats, EPH (5, 10 or 20 mg.Kg-1 i.v.) injections produced hypotension (-5.6±0.5; -8.8±1.3 and -32.6±6.6%, respectively) and bradicardia (-0.30.9; - 4.42.2 and -45.36.0%, respectively) (n=6). After acute treatment with a muscarinic agonist (atropine, 2 mg.Kg-1, hypotension (-5.0 ± 0.8, -6.4 ± 0.9 and -11.6 ± 1.8%, respectively ) and bradicardia (-1.2 ± 0.4, -2.9 ± 0.8 and -8.1 ± 2.2%) were significantly attenuated. Hexamethonium, a ganglionic blocker, also attenuated the effect of EPH. After L-NAME both answers were not modified. In isolated rat mesenteric artery rings, with intact endothelium, EPH (1, 3, 10, 30 and 100g/mL) induced concentration-dependent relaxation of the contractions induced by Phe (10 M) (EC50=17.14±2.9; Emax=87.8±2.9, n=8) and this effect was abolished by removal of vascular endothelium, suggesting the involvement of a mechanism endothelium-dependent. Fractions and 2-3dihydromyricetin-3-O--L-rhamnoside isolated from EPH did not relax or relaxed with less potency and effectiveness the preparation pre-contracted with Phe. The concentration-response curve for EPH was significantly shifted to the right with L-NAME (100 M), ODQ (1M), KCl 20mM, indomethacin (1M) + L-NAME (100M), 4-AP (1mM), BaCl2 (30 μM), TEA (1mM). In the presence of L-NAME (100M) + L-arginine (1mM) EHP relaxed preparations without changing the Emax. EPH did not induce relaxation on KCl 80 mM precontracted rings. Once in the presence of atropine (1M), indomethacin (1M), glibenclamide (10M) and apamin (1μM) the curve of EPH was not altered. We concluded that the hypotensive effect of EPH seems result of its vasorelaxant action and can involve an indirect activation of muscarinic heart receptors and still that the vascular effect of EPH can involve the activation of the eNOS-NO-GMPc ways well as the participation of BKCa, KV, and Kir potassium channels in vascular smooth muscle. EAE (5, 10, 20, 40 and 60 mg/kg i.v.) induced hypotension (- 3.7±1.2; -6.1±2.3; -8.5±1.3; -9.9±1.6 and -11.2±1.8%, respectively) and tachycardia (3.8±1.7; 4.0±1.6; 3.8±2.0; 3.7±3.1 and 12.4±2.7%, respectively) (n=5) probably due to a reflex response. In isolated rat mesenteric artery rings, EAE (1, 3, 10, 30, 100, 300, 500 and 1000 g/mL)induced relaxation in a concentration-dependent manner in both intact-(EC50 = 172.3 ± 36.9, Emax = 100 ± 0.0%) or removed-endothelium rings (EC50 = 166,7±31,4, Emáx = 92,2±7,1%) pre-contracted with Phe 10M with the same potency and effectiveness (n=6). These results suggest that EAE acts by an endothelium-independent mechanism. Subsequent experiments were accomplished in preparations without endothelium. In preparation pre-incubated with KCl 20 mM, the vasorelaxant activity of EAE was not changed (EC50 = 108.1 ± 10.7 and Emáx = 95.9 ± 4.4%). EAE relaxed with the same potency rings precontracted with KCl 80 mM (Emax = 97.1 ± 1.5%) or with Phe (Emax = 92.2 ± 7.1%) suggesting that EAE acts on the voltage-dependent Ca2+-channels. Furthermore, in depolarizing medium nominally without Ca2+, EAE antagonized CaCl2-induced contractions in a concentrationdependent manner. EAE (1, 3, 10, 30, 100, 300, 500 and 1000 g/mL) induced relaxation concentration-dependent, contractions elicited by the L-type Ca2+ channel agonist, S(-)-Bay K 8644 (Emáx = 128.8±5.8%, n=8). EAE did not alter transient contractions induced by caffeine (20 mM) and little influenced those induced by Phe (10 M). In rat isolated atrium, EAE produced negative inotropic and cronotropic effect. Electrophysiological studies on cells A7r5 (100 M) EAE inhibited Ba2+ current through the CaVL1.2. In conclusion, the results suggested that the hypotensive effect of EAE is due to its vasorelaxant action that seems to be attributed to the influx of Ca2+ through CaV 1.2 channels in vascular myocytes.
id UFPB-2_47784e7399ace039f360faa1bdef3cf0
oai_identifier_str oai:repositorio.ufpb.br:tede/6861
network_acronym_str UFPB-2
network_name_str Repositório Institucional da UFPB
repository_id_str
spelling Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratosStudy of activity of species amazon: Pradosia huberi Ducke. and Attalea excelsa Mart. on the cardiovascular system of ratsPradosia huberiAttalea excelsaArtéria mesentéricaVasorelaxantePradosia huberiAttalea excelsaMesenteric arteryVasorelaxanteCIENCIAS BIOLOGICAS::FARMACOLOGIAThe pharmacological effects of Pradosia huberi (EHP) and Attalea excelsa (EAE) ethanolics extracts on the cardiovascular system were studied in rats using a combined in vivo and in vitro approach. In non-anaesthetized rats, EPH (5, 10 or 20 mg.Kg-1 i.v.) injections produced hypotension (-5.6±0.5; -8.8±1.3 and -32.6±6.6%, respectively) and bradicardia (-0.30.9; - 4.42.2 and -45.36.0%, respectively) (n=6). After acute treatment with a muscarinic agonist (atropine, 2 mg.Kg-1, hypotension (-5.0 ± 0.8, -6.4 ± 0.9 and -11.6 ± 1.8%, respectively ) and bradicardia (-1.2 ± 0.4, -2.9 ± 0.8 and -8.1 ± 2.2%) were significantly attenuated. Hexamethonium, a ganglionic blocker, also attenuated the effect of EPH. After L-NAME both answers were not modified. In isolated rat mesenteric artery rings, with intact endothelium, EPH (1, 3, 10, 30 and 100g/mL) induced concentration-dependent relaxation of the contractions induced by Phe (10 M) (EC50=17.14±2.9; Emax=87.8±2.9, n=8) and this effect was abolished by removal of vascular endothelium, suggesting the involvement of a mechanism endothelium-dependent. Fractions and 2-3dihydromyricetin-3-O--L-rhamnoside isolated from EPH did not relax or relaxed with less potency and effectiveness the preparation pre-contracted with Phe. The concentration-response curve for EPH was significantly shifted to the right with L-NAME (100 M), ODQ (1M), KCl 20mM, indomethacin (1M) + L-NAME (100M), 4-AP (1mM), BaCl2 (30 μM), TEA (1mM). In the presence of L-NAME (100M) + L-arginine (1mM) EHP relaxed preparations without changing the Emax. EPH did not induce relaxation on KCl 80 mM precontracted rings. Once in the presence of atropine (1M), indomethacin (1M), glibenclamide (10M) and apamin (1μM) the curve of EPH was not altered. We concluded that the hypotensive effect of EPH seems result of its vasorelaxant action and can involve an indirect activation of muscarinic heart receptors and still that the vascular effect of EPH can involve the activation of the eNOS-NO-GMPc ways well as the participation of BKCa, KV, and Kir potassium channels in vascular smooth muscle. EAE (5, 10, 20, 40 and 60 mg/kg i.v.) induced hypotension (- 3.7±1.2; -6.1±2.3; -8.5±1.3; -9.9±1.6 and -11.2±1.8%, respectively) and tachycardia (3.8±1.7; 4.0±1.6; 3.8±2.0; 3.7±3.1 and 12.4±2.7%, respectively) (n=5) probably due to a reflex response. In isolated rat mesenteric artery rings, EAE (1, 3, 10, 30, 100, 300, 500 and 1000 g/mL)induced relaxation in a concentration-dependent manner in both intact-(EC50 = 172.3 ± 36.9, Emax = 100 ± 0.0%) or removed-endothelium rings (EC50 = 166,7±31,4, Emáx = 92,2±7,1%) pre-contracted with Phe 10M with the same potency and effectiveness (n=6). These results suggest that EAE acts by an endothelium-independent mechanism. Subsequent experiments were accomplished in preparations without endothelium. In preparation pre-incubated with KCl 20 mM, the vasorelaxant activity of EAE was not changed (EC50 = 108.1 ± 10.7 and Emáx = 95.9 ± 4.4%). EAE relaxed with the same potency rings precontracted with KCl 80 mM (Emax = 97.1 ± 1.5%) or with Phe (Emax = 92.2 ± 7.1%) suggesting that EAE acts on the voltage-dependent Ca2+-channels. Furthermore, in depolarizing medium nominally without Ca2+, EAE antagonized CaCl2-induced contractions in a concentrationdependent manner. EAE (1, 3, 10, 30, 100, 300, 500 and 1000 g/mL) induced relaxation concentration-dependent, contractions elicited by the L-type Ca2+ channel agonist, S(-)-Bay K 8644 (Emáx = 128.8±5.8%, n=8). EAE did not alter transient contractions induced by caffeine (20 mM) and little influenced those induced by Phe (10 M). In rat isolated atrium, EAE produced negative inotropic and cronotropic effect. Electrophysiological studies on cells A7r5 (100 M) EAE inhibited Ba2+ current through the CaVL1.2. In conclusion, the results suggested that the hypotensive effect of EAE is due to its vasorelaxant action that seems to be attributed to the influx of Ca2+ through CaV 1.2 channels in vascular myocytes.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESOs efeitos farmacológicos dos extratos etanólicos de Pradosia huberi (EPH) e Attalea excelsa (EAE) sobre o sistema cardiovascular, foram estudados em ratos usando técnicas in vivo e in vitro. EPH (5, 10 e 20 mg.Kg-1 i.v.) promoveu hipotensão (-5,6±0,5; -8,8±1,3 e - 32,6±6,6%, respectivamente) dose-dependente em ratos não anestesiados, acompanhada por bradicardia (-0,30,9; -4,42,2 e -45,36,0%, respectivamente) (n=6). Após tratamento agudo com um antagonista muscarínico (Atropina, 2 mg.Kg-1), a hipotensão (-5,0±0,8; - 6,4±0,9; -11,6±1,8%, respectivamente) e bradicardia (-1,2±0,4; -2,9±0,8 e -8,1±2,2%) foram significantemente atenuados. O hexametônio, um bloqueador ganglionar, também atenuou tais efeitos de EPH. Entretanto após L-NAME ambas as respostas não foram modificadas. Em anéis de artéria mesentérica superior isolada de rato, com endotélio intacto, EPH (1; 3; 10; 30 e 100g/mL) promoveu relaxamento das contrações induzidas por FEN (10 M) (CE50= 17,14±2,9; Emax= 87,8±2,9, n=8) de maneira dependente de concentração. Tal efeito foi abolido com a remoção do endotélio funcional, sugerindo o envolvimento de um mecanismo dependente do endotélio. Frações e a 2,3-diidromiricetina 3--L-raminosídeo, isolada de EPH, não relaxaram ou relaxaram com menos potencia e eficácia as preparação pré-contraídas com FEN. A curva concentração-resposta para EPH foi significantemente atenuada com redução do efeito máximo (Emax), na presença de L-NAME (100 M), ODQ (1M), KCl 20mM, indometacina(1M) + L-NAME (100M), 4-AP (1mM), BaCl2 (30 μM), TEA (1mM). Na presença de L-NAME (100M) + L-arginina (1mM) EPH relaxou as preparações sem alterar o Emax. Em anéis pré-contraídos com KCl 80mM EPH não induziu relaxamento. Já na presença de atropina (1M), indometacina (1M), glibenclamida (10M) e apamina (1μM) a curva para EPH não foi alterada. Em suma, concluímos que o efeito hipotensor de EPH envolve tanto sua ação vasorelaxante como também uma possível ativação indireta de receptores muscarínicos cardíacos e ainda que o efeito vascular de EPH pode envolver a ativação da via eNOS-NO-GMPc, além da participação dos canais para potássio do tipo BKCa, Kv e Kir na musculatura lisa vascular. EAE (5; 10; 20; 40 e 60 mg/kg i.v.) induziu hipotensão (-3,7±1,2; -6,1±2,3; -8,5±1,3; -9,9±1,6 e -11,2±1,8%, respectivamente) e taquicardia (3,8±1,7; 4,0±1,6; 3,8±2,0; 3,7±3,1 e 12,4±2,7%, respectivamente) (n=5), provavelmente de origem reflexa. Em anéis de artéria mesentérica superior isolada de rato, EAE (1; 3; 10; 30; 100; 300; 500 e 1000 g/mL) induziu relaxamento dependente da concentração tanto em anéis intactos (CE50 = 172,3±36,9 , Emáx = 100±0,0%) como desnudos de endotélio (CE50 = 166,7±31,4, Emáx = 92,2±7,1%), pré-contraídos com 10 M de FEN, com mesma potencia e eficácia (n=6). Sugerindo EAE age por mecanismo independente do endotélio. Os experimentos subseqüentes procederam-se em preparações sem endotélio. Diante da incubação com KCl 20 mM, o efeito vasorelaxante de EAE não foi alterado (CE50 = 108,1 ± 10,7 e Emáx = 95,9 ± 4,4%). EAE relaxou com mesma potencia anéis sem endotélio pré-contraídos pelo KCl 80 Mm (Emax= 97,1 ± 1,5%) e pela FEN (Emáx = 92,2±7,1%). Sugerindo que EAE atua sobre os canais para Ca2+ dependentes de voltagem. Adicionalmente, EAE antagonizou de maneira dependente de concentração as contrações induzidas por CaCl2 em meio despolarizante nominalmente sem Ca2+. EAE (1; 3; 10; 30; 100; 300; 500 e 1000g/mL) relaxou contrações induzidas pelo S(-)-Bay K 8644 (Emáx = 128,8±5,8%, n=8), um agonista de canais para Ca2+ tipo-L. EAE não alterou as contrações transientes induzidas por cafeína (20 mM) e pouco influenciou aquelas induzidas pela FEN (10 μM). Em átrio isolado de rato, EAE ocasionou cronotropismo e inotropismo negativo. Estudos eletrofisiológicos em células A7r5 (100 μM) EAE inibiu correntes de Ba2+ através dos CaVL1.2. Em conclusão, sugere-se que o efeito hipotensor de EAE é resultado de sua ação vasorelaxante que parece decorrente da sua ação sobre o influxo de cálcio através dos CaV 1.2 nos miocitos vasculares.Universidade Federal da Paraí­baBRFarmacologiaPrograma de Pós-Graduação em Produtos Naturais e Sintéticos BioativosUFPBMedeiros, Isac Almeida dehttp://lattes.cnpq.br/3412816427200150Diniz, Margareth de Fátima Formiga Melohttp://lattes.cnpq.br/4173269414899195Medeiros, Alessandra Azevedo Nascimento de2015-05-14T13:00:15Z2018-07-21T00:24:47Z2011-02-092018-07-21T00:24:47Z2008-12-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfMEDEIROS, Alessandra Azevedo Nascimento de. Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos. 2008. 180 f. Tese (Doutorado em Produtos Naturais e Sintéticos Bioativos) - Universidade Federal da Paraí­ba, João Pessoa, 2008.https://repositorio.ufpb.br/jspui/handle/tede/6861porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFPBinstname:Universidade Federal da Paraíba (UFPB)instacron:UFPB2018-09-06T01:38:18Zoai:repositorio.ufpb.br:tede/6861Repositório InstitucionalPUBhttps://repositorio.ufpb.br/oai/requestdiretoria@ufpb.br||bdtd@biblioteca.ufpb.bropendoar:25462018-09-06T01:38:18Repositório Institucional da UFPB - Universidade Federal da Paraíba (UFPB)false
dc.title.none.fl_str_mv Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos
Study of activity of species amazon: Pradosia huberi Ducke. and Attalea excelsa Mart. on the cardiovascular system of rats
title Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos
spellingShingle Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos
Medeiros, Alessandra Azevedo Nascimento de
Pradosia huberi
Attalea excelsa
Artéria mesentérica
Vasorelaxante
Pradosia huberi
Attalea excelsa
Mesenteric artery
Vasorelaxante
CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos
title_full Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos
title_fullStr Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos
title_full_unstemmed Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos
title_sort Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos
author Medeiros, Alessandra Azevedo Nascimento de
author_facet Medeiros, Alessandra Azevedo Nascimento de
author_role author
dc.contributor.none.fl_str_mv Medeiros, Isac Almeida de
http://lattes.cnpq.br/3412816427200150
Diniz, Margareth de Fátima Formiga Melo
http://lattes.cnpq.br/4173269414899195
dc.contributor.author.fl_str_mv Medeiros, Alessandra Azevedo Nascimento de
dc.subject.por.fl_str_mv Pradosia huberi
Attalea excelsa
Artéria mesentérica
Vasorelaxante
Pradosia huberi
Attalea excelsa
Mesenteric artery
Vasorelaxante
CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Pradosia huberi
Attalea excelsa
Artéria mesentérica
Vasorelaxante
Pradosia huberi
Attalea excelsa
Mesenteric artery
Vasorelaxante
CIENCIAS BIOLOGICAS::FARMACOLOGIA
description The pharmacological effects of Pradosia huberi (EHP) and Attalea excelsa (EAE) ethanolics extracts on the cardiovascular system were studied in rats using a combined in vivo and in vitro approach. In non-anaesthetized rats, EPH (5, 10 or 20 mg.Kg-1 i.v.) injections produced hypotension (-5.6±0.5; -8.8±1.3 and -32.6±6.6%, respectively) and bradicardia (-0.30.9; - 4.42.2 and -45.36.0%, respectively) (n=6). After acute treatment with a muscarinic agonist (atropine, 2 mg.Kg-1, hypotension (-5.0 ± 0.8, -6.4 ± 0.9 and -11.6 ± 1.8%, respectively ) and bradicardia (-1.2 ± 0.4, -2.9 ± 0.8 and -8.1 ± 2.2%) were significantly attenuated. Hexamethonium, a ganglionic blocker, also attenuated the effect of EPH. After L-NAME both answers were not modified. In isolated rat mesenteric artery rings, with intact endothelium, EPH (1, 3, 10, 30 and 100g/mL) induced concentration-dependent relaxation of the contractions induced by Phe (10 M) (EC50=17.14±2.9; Emax=87.8±2.9, n=8) and this effect was abolished by removal of vascular endothelium, suggesting the involvement of a mechanism endothelium-dependent. Fractions and 2-3dihydromyricetin-3-O--L-rhamnoside isolated from EPH did not relax or relaxed with less potency and effectiveness the preparation pre-contracted with Phe. The concentration-response curve for EPH was significantly shifted to the right with L-NAME (100 M), ODQ (1M), KCl 20mM, indomethacin (1M) + L-NAME (100M), 4-AP (1mM), BaCl2 (30 μM), TEA (1mM). In the presence of L-NAME (100M) + L-arginine (1mM) EHP relaxed preparations without changing the Emax. EPH did not induce relaxation on KCl 80 mM precontracted rings. Once in the presence of atropine (1M), indomethacin (1M), glibenclamide (10M) and apamin (1μM) the curve of EPH was not altered. We concluded that the hypotensive effect of EPH seems result of its vasorelaxant action and can involve an indirect activation of muscarinic heart receptors and still that the vascular effect of EPH can involve the activation of the eNOS-NO-GMPc ways well as the participation of BKCa, KV, and Kir potassium channels in vascular smooth muscle. EAE (5, 10, 20, 40 and 60 mg/kg i.v.) induced hypotension (- 3.7±1.2; -6.1±2.3; -8.5±1.3; -9.9±1.6 and -11.2±1.8%, respectively) and tachycardia (3.8±1.7; 4.0±1.6; 3.8±2.0; 3.7±3.1 and 12.4±2.7%, respectively) (n=5) probably due to a reflex response. In isolated rat mesenteric artery rings, EAE (1, 3, 10, 30, 100, 300, 500 and 1000 g/mL)induced relaxation in a concentration-dependent manner in both intact-(EC50 = 172.3 ± 36.9, Emax = 100 ± 0.0%) or removed-endothelium rings (EC50 = 166,7±31,4, Emáx = 92,2±7,1%) pre-contracted with Phe 10M with the same potency and effectiveness (n=6). These results suggest that EAE acts by an endothelium-independent mechanism. Subsequent experiments were accomplished in preparations without endothelium. In preparation pre-incubated with KCl 20 mM, the vasorelaxant activity of EAE was not changed (EC50 = 108.1 ± 10.7 and Emáx = 95.9 ± 4.4%). EAE relaxed with the same potency rings precontracted with KCl 80 mM (Emax = 97.1 ± 1.5%) or with Phe (Emax = 92.2 ± 7.1%) suggesting that EAE acts on the voltage-dependent Ca2+-channels. Furthermore, in depolarizing medium nominally without Ca2+, EAE antagonized CaCl2-induced contractions in a concentrationdependent manner. EAE (1, 3, 10, 30, 100, 300, 500 and 1000 g/mL) induced relaxation concentration-dependent, contractions elicited by the L-type Ca2+ channel agonist, S(-)-Bay K 8644 (Emáx = 128.8±5.8%, n=8). EAE did not alter transient contractions induced by caffeine (20 mM) and little influenced those induced by Phe (10 M). In rat isolated atrium, EAE produced negative inotropic and cronotropic effect. Electrophysiological studies on cells A7r5 (100 M) EAE inhibited Ba2+ current through the CaVL1.2. In conclusion, the results suggested that the hypotensive effect of EAE is due to its vasorelaxant action that seems to be attributed to the influx of Ca2+ through CaV 1.2 channels in vascular myocytes.
publishDate 2008
dc.date.none.fl_str_mv 2008-12-15
2011-02-09
2015-05-14T13:00:15Z
2018-07-21T00:24:47Z
2018-07-21T00:24:47Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv MEDEIROS, Alessandra Azevedo Nascimento de. Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos. 2008. 180 f. Tese (Doutorado em Produtos Naturais e Sintéticos Bioativos) - Universidade Federal da Paraí­ba, João Pessoa, 2008.
https://repositorio.ufpb.br/jspui/handle/tede/6861
identifier_str_mv MEDEIROS, Alessandra Azevedo Nascimento de. Estudo da atividade das espécies amazônicas: Pradosia huberi Ducke. e Attalea excelsa Mart. sobre o sistema cardiovascular em ratos. 2008. 180 f. Tese (Doutorado em Produtos Naturais e Sintéticos Bioativos) - Universidade Federal da Paraí­ba, João Pessoa, 2008.
url https://repositorio.ufpb.br/jspui/handle/tede/6861
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal da Paraí­ba
BR
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
publisher.none.fl_str_mv Universidade Federal da Paraí­ba
BR
Farmacologia
Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos
UFPB
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFPB
instname:Universidade Federal da Paraíba (UFPB)
instacron:UFPB
instname_str Universidade Federal da Paraíba (UFPB)
instacron_str UFPB
institution UFPB
reponame_str Repositório Institucional da UFPB
collection Repositório Institucional da UFPB
repository.name.fl_str_mv Repositório Institucional da UFPB - Universidade Federal da Paraíba (UFPB)
repository.mail.fl_str_mv diretoria@ufpb.br||bdtd@biblioteca.ufpb.br
_version_ 1863378981107007488